Novo Nordisk | Betriebsaufwand



Operating Expenses Veränderung Datum
ANI Pharmaceuticals USD 194.95M 211M 2024-12
Aurora Cannabis CAD 51.98M 31.53M 2024-12
Bausch Health Companies USD 1.98B 32M 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Canopy Growth CAD 98.58M 10.03M 2024-12
Corcept Therapeutics USD 156.63M 20.68M 2024-12
Drreddys Laboratories INR 64.87B 2.26B 2024-12
Eli Lilly USD 7.32B 1.06B 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Merck USD 9.66B 1.67B 2025-03
Novartis USD 11.28B 1.73B 2024-12
Novo Nordisk 37.49B 4.64B 2024-09
Novo Nordisk DKK 37.49B 4.64B 2024-09
Pacira USD 162.55M 145.55M 2024-12
Perrigo USD 1.03B 13.4M 2024-12
Prestige Brands USD 198.36M 1.09M 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
Zoetis USD 1.59B 71M 2024-12



Novo Nordisk Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.